CIK 0001913577 · Pharmaceutical Preparations (SIC 2834) · OTC, OTC · incorporated in DE · fiscal year ends 12/31
| FY2024 | FY2023 | |
|---|---|---|
| Net income (USD) | 632536 | -419390 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-08-10 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-07 | 424B3 | 424B3 | |
| 2026-07-07 | 8-K | 8-K items 1.01,3.02,7.01,9.01 | 2026-07-03 |
| 2026-07-01 | 424B3 | 424B3 | |
| 2026-06-26 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-06-26 | 4 | 4 | 2026-06-15 |
| 2026-06-25 | 8-K | 8-K items 5.07,9.01 | 2026-06-25 |
| 2026-06-15 | 424B3 | 424B3 | |
| 2026-06-15 | 424B3 | 424B3 | |
| 2026-05-18 | EFFECT | EFFECT items ,, | |
| 2026-05-13 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-12 | POS AM | POS AM | |
| 2026-04-30 | ARS | ARS | 2025-12-31 |
| 2026-04-30 | DEF 14A | DEF 14A | 2026-06-25 |
| 2026-04-23 | 8-K | 8-K items 1.02 | 2026-04-20 |
| 2026-03-17 | 8-K | 8-K items 5.02,9.01 | 2026-03-13 |
| 2026-02-27 | 10-K | 10-K | 2025-12-31 |
| 2025-12-29 | EFFECT | EFFECT items ,, | |
| 2025-12-29 | 424B3 | 424B3 | |
| 2025-12-23 | CORRESP | CORRESP | |
| 2025-12-19 | S-1/A | S-1/A | |
| 2025-12-03 | S-8 | S-8 | |
| 2025-12-03 | S-8 | S-8 | |
| 2025-12-03 | 8-K | 8-K items 8.01,9.01 | 2025-12-03 |
| 2025-11-12 | 10-Q | 10-Q | 2025-09-30 |
Forms on file (last 1,000): 8-K 45, 425 30, 3 15, 10-Q 14, SC 13G/A 12, SC 13G 12, CORRESP 10, 4 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=SMNR (0.002 USD), /gw/filings/filings?ticker=SMNR&form=8-K, /gw/filings/facts?ticker=SMNR&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange